MARKET

QURE

QURE

Uniqure
NASDAQ
23.03
+1.14
+5.21%
Pre Market: 23.35 +0.32 +1.39% 09:13 12/18 EST
OPEN
22.87
PREV CLOSE
21.89
HIGH
25.71
LOW
22.76
VOLUME
8.47K
TURNOVER
0
52 WEEK HIGH
71.50
52 WEEK LOW
7.76
MARKET CAP
1.43B
P/E (TTM)
-5.2518
1D
5D
1M
3M
1Y
5Y
1D
uniQure: Why Waiting For Clarity Beats Chasing The Next Step Jump
Seeking Alpha · 4h ago
Does uniQure (QURE) FDA Feedback on AMT-130 Reframe Its Risk, Funding and Strategy Profile?
Simply Wall St · 16h ago
Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday
Benzinga · 1d ago
QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
PR Newswire · 1d ago
uniQure call volume above normal and directionally bullish
TipRanks · 1d ago
What's Going On With uniQure Stock On Tuesday?
Benzinga · 2d ago
uniQure (QURE) Valuation Update After FDA Feedback Clouds AMT-130’s Current Path to a Biologics Filing
Simply Wall St · 2d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 2d ago
More
About QURE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

Webull offers Uniqure NV stock information, including NASDAQ: QURE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QURE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QURE stock methods without spending real money on the virtual paper trading platform.